Global Psoriasis Biologics Drugs Production, Demand and Key Producers, 2022-2028
This report studies the global Psoriasis Biologics Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Psoriasis Biologics Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Psoriasis Biologics Drugs that contribute to its increasing demand across many markets.
The global Psoriasis Biologics Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Psoriasis Biologics Drugs total production and demand, 2017-2028, (K Units)
Global Psoriasis Biologics Drugs total production value, 2017-2028, (USD Million)
Global Psoriasis Biologics Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Psoriasis Biologics Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Psoriasis Biologics Drugs domestic production, consumption, key domestic manufacturers and share
Global Psoriasis Biologics Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Psoriasis Biologics Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Psoriasis Biologics Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Psoriasis Biologics Drugs market based on the following parameters – headquarters, production locations, products portfolio, Psoriasis Biologics Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Psoriasis Biologics Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Psoriasis Biologics Drugs Market, By Region:
1. How big is the global Psoriasis Biologics Drugs market?
2. What is the demand of the global Psoriasis Biologics Drugs market?
3. What is the year over year growth of the global Psoriasis Biologics Drugs market?
4. What is the production and production value of the global Psoriasis Biologics Drugs market?
5. Who are the key producers in the global Psoriasis Biologics Drugs market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Psoriasis Biologics Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Psoriasis Biologics Drugs that contribute to its increasing demand across many markets.
The global Psoriasis Biologics Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Psoriasis Biologics Drugs total production and demand, 2017-2028, (K Units)
Global Psoriasis Biologics Drugs total production value, 2017-2028, (USD Million)
Global Psoriasis Biologics Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Psoriasis Biologics Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Psoriasis Biologics Drugs domestic production, consumption, key domestic manufacturers and share
Global Psoriasis Biologics Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Psoriasis Biologics Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Psoriasis Biologics Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Psoriasis Biologics Drugs market based on the following parameters – headquarters, production locations, products portfolio, Psoriasis Biologics Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Psoriasis Biologics Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Psoriasis Biologics Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- TNF-? Inhibitor
- IL-12/23 Target Drug
- IL-17 Target Drug
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Amgen
- UCB
- Johnson & Johnson
- Abbive
- Innovent
- Biocad
- Novartis
- Eli Lilly
- Sun Pharmaceutical
1. How big is the global Psoriasis Biologics Drugs market?
2. What is the demand of the global Psoriasis Biologics Drugs market?
3. What is the year over year growth of the global Psoriasis Biologics Drugs market?
4. What is the production and production value of the global Psoriasis Biologics Drugs market?
5. Who are the key producers in the global Psoriasis Biologics Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Psoriasis Biologics Drugs Introduction
1.2 World Psoriasis Biologics Drugs Supply & Forecast
1.2.1 World Psoriasis Biologics Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Psoriasis Biologics Drugs Production (2017-2028)
1.2.3 World Psoriasis Biologics Drugs Pricing Trends (2017-2028)
1.3 World Psoriasis Biologics Drugs Production by Region
1.3.1 World Psoriasis Biologics Drugs Production Value by Region (2017-2028)
1.3.2 World Psoriasis Biologics Drugs Production by Region (2017-2028)
1.3.3 World Psoriasis Biologics Drugs Average Price by Region (2017-2028)
1.3.4 North America Psoriasis Biologics Drugs Production (2017-2028)
1.3.5 Europe Psoriasis Biologics Drugs Production (2017-2028)
1.3.6 China Psoriasis Biologics Drugs Production (2017-2028)
1.3.7 Japan Psoriasis Biologics Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Psoriasis Biologics Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Psoriasis Biologics Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Psoriasis Biologics Drugs Demand (2017-2028)
2.2 World Psoriasis Biologics Drugs Consumption by Region
2.2.1 World Psoriasis Biologics Drugs Consumption by Region (2017-2022)
2.2.2 World Psoriasis Biologics Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Psoriasis Biologics Drugs Consumption (2017-2028)
2.4 China Psoriasis Biologics Drugs Consumption (2017-2028)
2.5 Europe Psoriasis Biologics Drugs Consumption (2017-2028)
2.6 Japan Psoriasis Biologics Drugs Consumption (2017-2028)
2.7 South Korea Psoriasis Biologics Drugs Consumption (2017-2028)
2.8 ASEAN Psoriasis Biologics Drugs Consumption (2017-2028)
2.9 India Psoriasis Biologics Drugs Consumption (2017-2028)
3 WORLD PSORIASIS BIOLOGICS DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Psoriasis Biologics Drugs Production Value by Manufacturer (2017-2022)
3.2 World Psoriasis Biologics Drugs Production by Manufacturer (2017-2022)
3.3 World Psoriasis Biologics Drugs Average Price by Manufacturer (2017-2022)
3.4 Psoriasis Biologics Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Psoriasis Biologics Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Psoriasis Biologics Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Psoriasis Biologics Drugs in 2021
3.6 Psoriasis Biologics Drugs Market: Overall Company Footprint Analysis
3.6.1 Psoriasis Biologics Drugs Market: Region Footprint
3.6.2 Psoriasis Biologics Drugs Market: Company Product Type Footprint
3.6.3 Psoriasis Biologics Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Psoriasis Biologics Drugs Production Value Comparison
4.1.1 United States VS China: Psoriasis Biologics Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Psoriasis Biologics Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Psoriasis Biologics Drugs Production Comparison
4.2.1 United States VS China: Psoriasis Biologics Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Psoriasis Biologics Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Psoriasis Biologics Drugs Consumption Comparison
4.3.1 United States VS China: Psoriasis Biologics Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Psoriasis Biologics Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Psoriasis Biologics Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Psoriasis Biologics Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Psoriasis Biologics Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Psoriasis Biologics Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Psoriasis Biologics Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Psoriasis Biologics Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Psoriasis Biologics Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 TNF-? Inhibitor
5.2.2 IL-12/23 Target Drug
5.2.3 IL-17 Target Drug
5.3 Market Segment by Type
5.3.1 World Psoriasis Biologics Drugs Production by Type (2017-2028)
5.3.2 World Psoriasis Biologics Drugs Production Value by Type (2017-2028)
5.3.3 World Psoriasis Biologics Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Psoriasis Biologics Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Segment by Application
6.3.1 World Psoriasis Biologics Drugs Production by Application (2017-2028)
6.3.2 World Psoriasis Biologics Drugs Production Value by Application (2017-2028)
6.3.3 World Psoriasis Biologics Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Details
7.1.2 Amgen Major Business
7.1.3 Amgen Psoriasis Biologics Drugs Product and Services
7.1.4 Amgen Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Amgen Recent Developments/Updates
7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 UCB
7.2.1 UCB Details
7.2.2 UCB Major Business
7.2.3 UCB Psoriasis Biologics Drugs Product and Services
7.2.4 UCB Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 UCB Recent Developments/Updates
7.2.6 UCB Competitive Strengths & Weaknesses
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Details
7.3.2 Johnson & Johnson Major Business
7.3.3 Johnson & Johnson Psoriasis Biologics Drugs Product and Services
7.3.4 Johnson & Johnson Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Johnson & Johnson Recent Developments/Updates
7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.4 Abbive
7.4.1 Abbive Details
7.4.2 Abbive Major Business
7.4.3 Abbive Psoriasis Biologics Drugs Product and Services
7.4.4 Abbive Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Abbive Recent Developments/Updates
7.4.6 Abbive Competitive Strengths & Weaknesses
7.5 Innovent
7.5.1 Innovent Details
7.5.2 Innovent Major Business
7.5.3 Innovent Psoriasis Biologics Drugs Product and Services
7.5.4 Innovent Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Innovent Recent Developments/Updates
7.5.6 Innovent Competitive Strengths & Weaknesses
7.6 Biocad
7.6.1 Biocad Details
7.6.2 Biocad Major Business
7.6.3 Biocad Psoriasis Biologics Drugs Product and Services
7.6.4 Biocad Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Biocad Recent Developments/Updates
7.6.6 Biocad Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis Psoriasis Biologics Drugs Product and Services
7.7.4 Novartis Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
7.8 Eli Lilly
7.8.1 Eli Lilly Details
7.8.2 Eli Lilly Major Business
7.8.3 Eli Lilly Psoriasis Biologics Drugs Product and Services
7.8.4 Eli Lilly Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Eli Lilly Recent Developments/Updates
7.8.6 Eli Lilly Competitive Strengths & Weaknesses
7.9 Sun Pharmaceutical
7.9.1 Sun Pharmaceutical Details
7.9.2 Sun Pharmaceutical Major Business
7.9.3 Sun Pharmaceutical Psoriasis Biologics Drugs Product and Services
7.9.4 Sun Pharmaceutical Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Sun Pharmaceutical Recent Developments/Updates
7.9.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Psoriasis Biologics Drugs and Key Manufacturers
8.2 Psoriasis Biologics Drugs Manufacturing Costs
8.3 Psoriasis Biologics Drugs Production Process
8.4 Psoriasis Biologics Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Psoriasis Biologics Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Psoriasis Biologics Drugs Typical Distributors
9.3 Psoriasis Biologics Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Psoriasis Biologics Drugs Introduction
1.2 World Psoriasis Biologics Drugs Supply & Forecast
1.2.1 World Psoriasis Biologics Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Psoriasis Biologics Drugs Production (2017-2028)
1.2.3 World Psoriasis Biologics Drugs Pricing Trends (2017-2028)
1.3 World Psoriasis Biologics Drugs Production by Region
1.3.1 World Psoriasis Biologics Drugs Production Value by Region (2017-2028)
1.3.2 World Psoriasis Biologics Drugs Production by Region (2017-2028)
1.3.3 World Psoriasis Biologics Drugs Average Price by Region (2017-2028)
1.3.4 North America Psoriasis Biologics Drugs Production (2017-2028)
1.3.5 Europe Psoriasis Biologics Drugs Production (2017-2028)
1.3.6 China Psoriasis Biologics Drugs Production (2017-2028)
1.3.7 Japan Psoriasis Biologics Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Psoriasis Biologics Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Psoriasis Biologics Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Psoriasis Biologics Drugs Demand (2017-2028)
2.2 World Psoriasis Biologics Drugs Consumption by Region
2.2.1 World Psoriasis Biologics Drugs Consumption by Region (2017-2022)
2.2.2 World Psoriasis Biologics Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Psoriasis Biologics Drugs Consumption (2017-2028)
2.4 China Psoriasis Biologics Drugs Consumption (2017-2028)
2.5 Europe Psoriasis Biologics Drugs Consumption (2017-2028)
2.6 Japan Psoriasis Biologics Drugs Consumption (2017-2028)
2.7 South Korea Psoriasis Biologics Drugs Consumption (2017-2028)
2.8 ASEAN Psoriasis Biologics Drugs Consumption (2017-2028)
2.9 India Psoriasis Biologics Drugs Consumption (2017-2028)
3 WORLD PSORIASIS BIOLOGICS DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Psoriasis Biologics Drugs Production Value by Manufacturer (2017-2022)
3.2 World Psoriasis Biologics Drugs Production by Manufacturer (2017-2022)
3.3 World Psoriasis Biologics Drugs Average Price by Manufacturer (2017-2022)
3.4 Psoriasis Biologics Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Psoriasis Biologics Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Psoriasis Biologics Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Psoriasis Biologics Drugs in 2021
3.6 Psoriasis Biologics Drugs Market: Overall Company Footprint Analysis
3.6.1 Psoriasis Biologics Drugs Market: Region Footprint
3.6.2 Psoriasis Biologics Drugs Market: Company Product Type Footprint
3.6.3 Psoriasis Biologics Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Psoriasis Biologics Drugs Production Value Comparison
4.1.1 United States VS China: Psoriasis Biologics Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Psoriasis Biologics Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Psoriasis Biologics Drugs Production Comparison
4.2.1 United States VS China: Psoriasis Biologics Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Psoriasis Biologics Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Psoriasis Biologics Drugs Consumption Comparison
4.3.1 United States VS China: Psoriasis Biologics Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Psoriasis Biologics Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Psoriasis Biologics Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Psoriasis Biologics Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Psoriasis Biologics Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Psoriasis Biologics Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Psoriasis Biologics Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Psoriasis Biologics Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Psoriasis Biologics Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 TNF-? Inhibitor
5.2.2 IL-12/23 Target Drug
5.2.3 IL-17 Target Drug
5.3 Market Segment by Type
5.3.1 World Psoriasis Biologics Drugs Production by Type (2017-2028)
5.3.2 World Psoriasis Biologics Drugs Production Value by Type (2017-2028)
5.3.3 World Psoriasis Biologics Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Psoriasis Biologics Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Segment by Application
6.3.1 World Psoriasis Biologics Drugs Production by Application (2017-2028)
6.3.2 World Psoriasis Biologics Drugs Production Value by Application (2017-2028)
6.3.3 World Psoriasis Biologics Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Details
7.1.2 Amgen Major Business
7.1.3 Amgen Psoriasis Biologics Drugs Product and Services
7.1.4 Amgen Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Amgen Recent Developments/Updates
7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 UCB
7.2.1 UCB Details
7.2.2 UCB Major Business
7.2.3 UCB Psoriasis Biologics Drugs Product and Services
7.2.4 UCB Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 UCB Recent Developments/Updates
7.2.6 UCB Competitive Strengths & Weaknesses
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Details
7.3.2 Johnson & Johnson Major Business
7.3.3 Johnson & Johnson Psoriasis Biologics Drugs Product and Services
7.3.4 Johnson & Johnson Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Johnson & Johnson Recent Developments/Updates
7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.4 Abbive
7.4.1 Abbive Details
7.4.2 Abbive Major Business
7.4.3 Abbive Psoriasis Biologics Drugs Product and Services
7.4.4 Abbive Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Abbive Recent Developments/Updates
7.4.6 Abbive Competitive Strengths & Weaknesses
7.5 Innovent
7.5.1 Innovent Details
7.5.2 Innovent Major Business
7.5.3 Innovent Psoriasis Biologics Drugs Product and Services
7.5.4 Innovent Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Innovent Recent Developments/Updates
7.5.6 Innovent Competitive Strengths & Weaknesses
7.6 Biocad
7.6.1 Biocad Details
7.6.2 Biocad Major Business
7.6.3 Biocad Psoriasis Biologics Drugs Product and Services
7.6.4 Biocad Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Biocad Recent Developments/Updates
7.6.6 Biocad Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis Psoriasis Biologics Drugs Product and Services
7.7.4 Novartis Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
7.8 Eli Lilly
7.8.1 Eli Lilly Details
7.8.2 Eli Lilly Major Business
7.8.3 Eli Lilly Psoriasis Biologics Drugs Product and Services
7.8.4 Eli Lilly Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Eli Lilly Recent Developments/Updates
7.8.6 Eli Lilly Competitive Strengths & Weaknesses
7.9 Sun Pharmaceutical
7.9.1 Sun Pharmaceutical Details
7.9.2 Sun Pharmaceutical Major Business
7.9.3 Sun Pharmaceutical Psoriasis Biologics Drugs Product and Services
7.9.4 Sun Pharmaceutical Psoriasis Biologics Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Sun Pharmaceutical Recent Developments/Updates
7.9.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Psoriasis Biologics Drugs and Key Manufacturers
8.2 Psoriasis Biologics Drugs Manufacturing Costs
8.3 Psoriasis Biologics Drugs Production Process
8.4 Psoriasis Biologics Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Psoriasis Biologics Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Psoriasis Biologics Drugs Typical Distributors
9.3 Psoriasis Biologics Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Psoriasis Biologics Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Psoriasis Biologics Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Psoriasis Biologics Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Psoriasis Biologics Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Psoriasis Biologics Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Psoriasis Biologics Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Psoriasis Biologics Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Psoriasis Biologics Drugs Production Market Share by Region (2017-2022)
Table 9. World Psoriasis Biologics Drugs Production Market Share by Region (2023-2028)
Table 10. World Psoriasis Biologics Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Psoriasis Biologics Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Psoriasis Biologics Drugs Major Market Trends
Table 13. World Psoriasis Biologics Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Psoriasis Biologics Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Psoriasis Biologics Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Psoriasis Biologics Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Psoriasis Biologics Drugs Producers in 2021
Table 18. World Psoriasis Biologics Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Psoriasis Biologics Drugs Producers in 2021
Table 20. World Psoriasis Biologics Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Psoriasis Biologics Drugs Company Evaluation Quadrant
Table 22. World Psoriasis Biologics Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Psoriasis Biologics Drugs Production Site of Key Manufacturer
Table 24. Psoriasis Biologics Drugs Market: Company Product Type Footprint
Table 25. Psoriasis Biologics Drugs Market: Company Product Application Footprint
Table 26. Psoriasis Biologics Drugs Competitive Factors
Table 27. Psoriasis Biologics Drugs New Entrant and Capacity Expansion Plans
Table 28. Psoriasis Biologics Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Psoriasis Biologics Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Psoriasis Biologics Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Psoriasis Biologics Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Psoriasis Biologics Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Psoriasis Biologics Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Psoriasis Biologics Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Psoriasis Biologics Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Psoriasis Biologics Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Psoriasis Biologics Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Psoriasis Biologics Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Psoriasis Biologics Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Psoriasis Biologics Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Psoriasis Biologics Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Psoriasis Biologics Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Psoriasis Biologics Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Psoriasis Biologics Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Psoriasis Biologics Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Psoriasis Biologics Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Psoriasis Biologics Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Psoriasis Biologics Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Psoriasis Biologics Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Psoriasis Biologics Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Psoriasis Biologics Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Psoriasis Biologics Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Psoriasis Biologics Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Psoriasis Biologics Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Psoriasis Biologics Drugs Product and Services
Table 64. Amgen Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. UCB Basic Information, Manufacturing Base and Competitors
Table 68. UCB Major Business
Table 69. UCB Psoriasis Biologics Drugs Product and Services
Table 70. UCB Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. UCB Recent Developments/Updates
Table 72. UCB Competitive Strengths & Weaknesses
Table 73. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 74. Johnson & Johnson Major Business
Table 75. Johnson & Johnson Psoriasis Biologics Drugs Product and Services
Table 76. Johnson & Johnson Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Johnson & Johnson Recent Developments/Updates
Table 78. Johnson & Johnson Competitive Strengths & Weaknesses
Table 79. Abbive Basic Information, Manufacturing Base and Competitors
Table 80. Abbive Major Business
Table 81. Abbive Psoriasis Biologics Drugs Product and Services
Table 82. Abbive Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Abbive Recent Developments/Updates
Table 84. Abbive Competitive Strengths & Weaknesses
Table 85. Innovent Basic Information, Manufacturing Base and Competitors
Table 86. Innovent Major Business
Table 87. Innovent Psoriasis Biologics Drugs Product and Services
Table 88. Innovent Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Innovent Recent Developments/Updates
Table 90. Innovent Competitive Strengths & Weaknesses
Table 91. Biocad Basic Information, Manufacturing Base and Competitors
Table 92. Biocad Major Business
Table 93. Biocad Psoriasis Biologics Drugs Product and Services
Table 94. Biocad Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Biocad Recent Developments/Updates
Table 96. Biocad Competitive Strengths & Weaknesses
Table 97. Novartis Basic Information, Manufacturing Base and Competitors
Table 98. Novartis Major Business
Table 99. Novartis Psoriasis Biologics Drugs Product and Services
Table 100. Novartis Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Novartis Recent Developments/Updates
Table 102. Novartis Competitive Strengths & Weaknesses
Table 103. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 104. Eli Lilly Major Business
Table 105. Eli Lilly Psoriasis Biologics Drugs Product and Services
Table 106. Eli Lilly Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Eli Lilly Recent Developments/Updates
Table 108. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 109. Sun Pharmaceutical Major Business
Table 110. Sun Pharmaceutical Psoriasis Biologics Drugs Product and Services
Table 111. Sun Pharmaceutical Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 112. Psoriasis Biologics Drugs Raw Material
Table 113. Key Manufacturers of Psoriasis Biologics Drugs Raw Materials
Table 114. Psoriasis Biologics Drugs Typical Distributors
Table 115. Psoriasis Biologics Drugs Typical Customers
Table 1. World Psoriasis Biologics Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Psoriasis Biologics Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Psoriasis Biologics Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Psoriasis Biologics Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Psoriasis Biologics Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Psoriasis Biologics Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Psoriasis Biologics Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Psoriasis Biologics Drugs Production Market Share by Region (2017-2022)
Table 9. World Psoriasis Biologics Drugs Production Market Share by Region (2023-2028)
Table 10. World Psoriasis Biologics Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Psoriasis Biologics Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Psoriasis Biologics Drugs Major Market Trends
Table 13. World Psoriasis Biologics Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Psoriasis Biologics Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Psoriasis Biologics Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Psoriasis Biologics Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Psoriasis Biologics Drugs Producers in 2021
Table 18. World Psoriasis Biologics Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Psoriasis Biologics Drugs Producers in 2021
Table 20. World Psoriasis Biologics Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Psoriasis Biologics Drugs Company Evaluation Quadrant
Table 22. World Psoriasis Biologics Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Psoriasis Biologics Drugs Production Site of Key Manufacturer
Table 24. Psoriasis Biologics Drugs Market: Company Product Type Footprint
Table 25. Psoriasis Biologics Drugs Market: Company Product Application Footprint
Table 26. Psoriasis Biologics Drugs Competitive Factors
Table 27. Psoriasis Biologics Drugs New Entrant and Capacity Expansion Plans
Table 28. Psoriasis Biologics Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Psoriasis Biologics Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Psoriasis Biologics Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Psoriasis Biologics Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Psoriasis Biologics Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Psoriasis Biologics Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Psoriasis Biologics Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Psoriasis Biologics Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Psoriasis Biologics Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Psoriasis Biologics Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Psoriasis Biologics Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Psoriasis Biologics Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Psoriasis Biologics Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Psoriasis Biologics Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Psoriasis Biologics Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Psoriasis Biologics Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Psoriasis Biologics Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Psoriasis Biologics Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Psoriasis Biologics Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Psoriasis Biologics Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Psoriasis Biologics Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Psoriasis Biologics Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Psoriasis Biologics Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Psoriasis Biologics Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Psoriasis Biologics Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Psoriasis Biologics Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Psoriasis Biologics Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Psoriasis Biologics Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Psoriasis Biologics Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Psoriasis Biologics Drugs Product and Services
Table 64. Amgen Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. UCB Basic Information, Manufacturing Base and Competitors
Table 68. UCB Major Business
Table 69. UCB Psoriasis Biologics Drugs Product and Services
Table 70. UCB Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. UCB Recent Developments/Updates
Table 72. UCB Competitive Strengths & Weaknesses
Table 73. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 74. Johnson & Johnson Major Business
Table 75. Johnson & Johnson Psoriasis Biologics Drugs Product and Services
Table 76. Johnson & Johnson Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Johnson & Johnson Recent Developments/Updates
Table 78. Johnson & Johnson Competitive Strengths & Weaknesses
Table 79. Abbive Basic Information, Manufacturing Base and Competitors
Table 80. Abbive Major Business
Table 81. Abbive Psoriasis Biologics Drugs Product and Services
Table 82. Abbive Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Abbive Recent Developments/Updates
Table 84. Abbive Competitive Strengths & Weaknesses
Table 85. Innovent Basic Information, Manufacturing Base and Competitors
Table 86. Innovent Major Business
Table 87. Innovent Psoriasis Biologics Drugs Product and Services
Table 88. Innovent Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Innovent Recent Developments/Updates
Table 90. Innovent Competitive Strengths & Weaknesses
Table 91. Biocad Basic Information, Manufacturing Base and Competitors
Table 92. Biocad Major Business
Table 93. Biocad Psoriasis Biologics Drugs Product and Services
Table 94. Biocad Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Biocad Recent Developments/Updates
Table 96. Biocad Competitive Strengths & Weaknesses
Table 97. Novartis Basic Information, Manufacturing Base and Competitors
Table 98. Novartis Major Business
Table 99. Novartis Psoriasis Biologics Drugs Product and Services
Table 100. Novartis Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Novartis Recent Developments/Updates
Table 102. Novartis Competitive Strengths & Weaknesses
Table 103. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 104. Eli Lilly Major Business
Table 105. Eli Lilly Psoriasis Biologics Drugs Product and Services
Table 106. Eli Lilly Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Eli Lilly Recent Developments/Updates
Table 108. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 109. Sun Pharmaceutical Major Business
Table 110. Sun Pharmaceutical Psoriasis Biologics Drugs Product and Services
Table 111. Sun Pharmaceutical Psoriasis Biologics Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 112. Psoriasis Biologics Drugs Raw Material
Table 113. Key Manufacturers of Psoriasis Biologics Drugs Raw Materials
Table 114. Psoriasis Biologics Drugs Typical Distributors
Table 115. Psoriasis Biologics Drugs Typical Customers
LIST OF FIGURES
Figure 1. Psoriasis Biologics Drugs Picture
Figure 2. World Psoriasis Biologics Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Psoriasis Biologics Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 5. World Psoriasis Biologics Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Psoriasis Biologics Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Psoriasis Biologics Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 10. China Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 12. Psoriasis Biologics Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Psoriasis Biologics Drugs Demand (2017-2028) & (K Units)
Figure 15. World Psoriasis Biologics Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Psoriasis Biologics Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Psoriasis Biologics Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Psoriasis Biologics Drugs Markets in 2021
Figure 26. United States VS China: Psoriasis Biologics Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Psoriasis Biologics Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Psoriasis Biologics Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Psoriasis Biologics Drugs in United States
Figure 30. Key Producers and Market Share of Psoriasis Biologics Drugs in China
Figure 31. Key Producers and Market Share of Psoriasis Biologics Drugs in Rest of World
Figure 32. World Psoriasis Biologics Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Psoriasis Biologics Drugs Production Value Market Share by Type in 2021
Figure 34. TNF-? Inhibitor
Figure 35. IL-12/23 Target Drug
Figure 36. IL-17 Target Drug
Figure 37. World Psoriasis Biologics Drugs Production Market Share by Type (2017-2028)
Figure 38. World Psoriasis Biologics Drugs Production Value Market Share by Type (2017-2028)
Figure 39. World Psoriasis Biologics Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Psoriasis Biologics Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Psoriasis Biologics Drugs Production Value Market Share by Application in 2021
Figure 42. Hospital Pharmacies
Figure 43. Retail Pharmacies
Figure 44. Online Pharmacies
Figure 45. World Psoriasis Biologics Drugs Production Market Share by Application (2017-2028)
Figure 46. World Psoriasis Biologics Drugs Production Value Market Share by Application (2017-2028)
Figure 47. World Psoriasis Biologics Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs in 2021
Figure 49. Manufacturing Process Analysis of Psoriasis Biologics Drugs
Figure 50. Psoriasis Biologics Drugs Industrial Chain
Figure 51. Distribution Channel Breakdown for Psoriasis Biologics Drugs Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Psoriasis Biologics Drugs Picture
Figure 2. World Psoriasis Biologics Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Psoriasis Biologics Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 5. World Psoriasis Biologics Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Psoriasis Biologics Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Psoriasis Biologics Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 10. China Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Psoriasis Biologics Drugs Production (2017-2028) & (K Units)
Figure 12. Psoriasis Biologics Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Psoriasis Biologics Drugs Demand (2017-2028) & (K Units)
Figure 15. World Psoriasis Biologics Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Psoriasis Biologics Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Psoriasis Biologics Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Psoriasis Biologics Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Psoriasis Biologics Drugs Markets in 2021
Figure 26. United States VS China: Psoriasis Biologics Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Psoriasis Biologics Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Psoriasis Biologics Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Psoriasis Biologics Drugs in United States
Figure 30. Key Producers and Market Share of Psoriasis Biologics Drugs in China
Figure 31. Key Producers and Market Share of Psoriasis Biologics Drugs in Rest of World
Figure 32. World Psoriasis Biologics Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Psoriasis Biologics Drugs Production Value Market Share by Type in 2021
Figure 34. TNF-? Inhibitor
Figure 35. IL-12/23 Target Drug
Figure 36. IL-17 Target Drug
Figure 37. World Psoriasis Biologics Drugs Production Market Share by Type (2017-2028)
Figure 38. World Psoriasis Biologics Drugs Production Value Market Share by Type (2017-2028)
Figure 39. World Psoriasis Biologics Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Psoriasis Biologics Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Psoriasis Biologics Drugs Production Value Market Share by Application in 2021
Figure 42. Hospital Pharmacies
Figure 43. Retail Pharmacies
Figure 44. Online Pharmacies
Figure 45. World Psoriasis Biologics Drugs Production Market Share by Application (2017-2028)
Figure 46. World Psoriasis Biologics Drugs Production Value Market Share by Application (2017-2028)
Figure 47. World Psoriasis Biologics Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs in 2021
Figure 49. Manufacturing Process Analysis of Psoriasis Biologics Drugs
Figure 50. Psoriasis Biologics Drugs Industrial Chain
Figure 51. Distribution Channel Breakdown for Psoriasis Biologics Drugs Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
